Bristol-Myers Squibb (BMY) Stock News Today: BofA Upgrade, Dividend Momentum and 2026 Pipeline Catalysts in Focus (Dec. 16, 2025)
Bristol-Myers Squibb Company (NYSE: BMY) is back in the spotlight on Tuesday, December 16, 2025, as investors weigh a fresh Bank of America upgrade, a renewed value debate around the stock’s multiple, and a growing list of 2026 pipeline catalysts that could shape the post–patent-cliff narrative. As of 2:00 p.m. (quotes delayed), BMY shares were $53.66, down 1.15% on the session, with a 52‑week range of $42.52 to $63.33. Bristol Myers Squibb BMY stock today: Where shares are trading and what that implies The mid‑$50s trading zone matters because it has become the market’s “battleground price” between two competing views: